DMEMEDS shared post via Reuters: Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints

NEW YORK/PARIS (Reuters) - A new drug being developed by Sanofi SA and Regeneron Pharmaceuticals Inc significantly cut cholesterol in nine late-stage clinical trials, the companies said on Wednesday, and provided the first glimpse of its potential to prevent heart attacks and strokes. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/fd1sC6j0TP8/story01.htm

Read More